Elkfork Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $999K | Buy |
7,920
+264
| +3% | +$33.3K | 0.02% | 386 |
|
|
2019
Q2 | $921K | Hold |
7,656
| – | – | 0.02% | 411 |
|
|
2019
Q1 | $670K | Buy |
7,656
+264
| +4% | +$23.1K | 0.02% | 484 |
|
|
2018
Q4 | $740K | Hold |
7,392
| – | – | 0.02% | 415 |
|
|
2018
Q3 | $847K | Buy |
7,392
+1,628
| +28% | +$187K | 0.02% | 425 |
|
|
2018
Q2 | $517K | Hold |
5,764
| – | – | 0.01% | 523 |
|
|
2018
Q1 | $422K | Hold |
5,764
| – | – | 0.01% | 576 |
|
|
2017
Q4 | $335K | Buy |
5,764
+990
| +21% | +$57.5K | 0.01% | 652 |
|
|
2017
Q3 | $214K | Buy |
4,774
+484
| +11% | +$21.7K | 0.01% | 720 |
|
|
2017
Q2 | $169K | Buy |
4,290
+1,980
| +86% | +$78K | 0.01% | 741 |
|
|
2017
Q1 | $94K | Hold |
2,310
| – | – | ﹤0.01% | 767 |
|
|
2016
Q4 | $93K | Buy |
+2,310
| New | +$93K | ﹤0.01% | 758 |
|